Highest-materiality recent filing
Quantum-Si Q1 net loss widens to $21.7M; Proteus sequencing milestones on track
Revenue of $258,000, gross margin 29%; net loss $21.7M vs $19.2M YoY.
Fourth quarter 2025 revenue was $451,000, gross margin 27%, and net loss $17.6 million.
Quantum-Si targets Proteus launch in Q4 2026 with 20-AA detection by 2027
Proteus product launch set for YE2026; first integrated system expected Q1 2026.
Revenue $552K; gross profit $194K, gross margin 35%.
Quantum-Si enters $100M at-the-market equity offering agreement with Leerink Partners
May offer and sell up to $100M of Class A common stock at its discretion through Leerink Partners as sales agent.
Quantum-Si pays $11M to settle lease litigation and terminate New Haven lease
Settles lawsuit with landlord Winchester Office LLC; terminates lease at 115 Munson St, New Haven effective Sept 23, 2025.
Quantum-Si Q2 revenue $591K, net loss $28.8M; raises $50M cash runway
Q2 2025 revenue $591K; gross margin 59%; net loss $28.8M vs $23.1M prior year.
Quantum-Si prices $50M registered direct offering of stock and pre-funded warrants at $1.67
Gross proceeds ~$50M from sale of 29,940,119 shares (including pre-funded warrants) at $1.67 per share.
Quantum-Si Q1 revenue $842K (+84% YoY); launches Platinum Pro, cash runway to H2 2027
Revenue $842K (+84% YoY); gross profit $486K, gross margin 58%.
Revenue $1.2M Q4 2024, $3.1M full year 2024 (+183% YoY). Gross margin 51% Q4, 52% FY.
Quantum-Si prices $50M registered direct offering of 15.6M shares at $3.20 each
Sold 15,625,000 shares at $3.20/share; gross proceeds ~$50M; closing expected Jan 6, 2025.
Quantum-Si to cut ~23% of workforce in restructuring; expects $2.6M in charges
Terminating approximately 23% of 187 employees; restructuring to streamline resources.
Quantum-Si corrects compliance date for Nasdaq bid price deficiency to May 5, 2025
Nasdaq notified Quantum-Si on Nov 4, 2024 that bid price below $1.00 for 30 consecutive days.
Quantum-Si Q3 revenue $787k; CEO warns full-year revenue guidance unlikely
Q3 2024 revenue $787k, gross margin 47%; net loss $25.3M vs $24.7M a year ago.
Quantum-Si receives Nasdaq bid price deficiency notice; must regain compliance by May 5, 2024
Closing bid price of Class A common stock (QSI) below $1.00 for 30 consecutive business days as of Nov 4, 2024.
Quantum-Si appoints Bennett as CCO, Vieceli as CPO, Thompson as CHRO; Johnston resigns
Todd Bennett appointed Chief Commercial Officer effective Sept 17, 2024; Grace Johnston resigns effective Sept 6.
Quantum-Si Q2 2024 revenue $622K, net loss narrows to $23.1M; launches v3 sequencing kit
Q2 revenue $622K, gross margin 57%; net loss $23.1M vs $25.6M YoY.
Quantum-Si discloses shareholder class action lawsuit over SPAC merger process
Lawsuit filed May 16, 2024 in Delaware Court of Chancery; plaintiff Farzad v. HighCape Capital, et al.
Quantum-Si Q4 rev $400k, net loss $22M; full commercial launch expected by end Q1 2024
Revenue $400k in Q4 2023, $1.1M for FY2023; gross margin 45%.
On August 21, 2024, Grace Johnston, Ph.D. delivered her resignation as the Chief Commercial Officer of Quantum-Si Incorporated (the “Company”), effective as of September 6, 2024.
The Company has appointed Todd Bennett as the Company’s new Chief Commercial Officer, effective as of September 17, 2024.
On May 27, 2024, the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) elected Charles (“Chuck”) Kummeth to the Board and appointed him as Chairperson of the Board, each effective as of May 27, 2024
the Company’s current Chairperson of the Board, Jonathan M. Rothberg, Ph.D., continues to serve as a director of the Company but ceased serving as Chairperson of the Board.
the Board of Directors (the “Board”) of Quantum-Si Incorporated (the “Company”) appointed Paula Dowdy to the Board, effective as of March 21, 2024.
Max materiality 0.80 · Median 0.60 · Most common event other_material